Anders Toft

1.6k total citations
30 papers, 1.2k citations indexed

About

Anders Toft is a scholar working on Rehabilitation, Molecular Biology and Cell Biology. According to data from OpenAlex, Anders Toft has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rehabilitation, 7 papers in Molecular Biology and 7 papers in Cell Biology. Recurrent topics in Anders Toft's work include Exercise and Physiological Responses (8 papers), Glioma Diagnosis and Treatment (6 papers) and Muscle metabolism and nutrition (6 papers). Anders Toft is often cited by papers focused on Exercise and Physiological Responses (8 papers), Glioma Diagnosis and Treatment (6 papers) and Muscle metabolism and nutrition (6 papers). Anders Toft collaborates with scholars based in Denmark, United Kingdom and United States. Anders Toft's co-authors include Bente Klarlund Pedersen, J Halkjær-Kristensen, Adam Steensberg, Helle Brüünsgaard, Lars Bjørn Jensen, Tobias Ibfelt, Mark A. Febbraio, Peter Schjerling, Sisse Rye Ostrowski and Bernard Zinman and has published in prestigious journals such as Diabetes, Journal of Applied Physiology and Diabetologia.

In The Last Decade

Anders Toft

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Toft Denmark 14 661 377 258 207 154 30 1.2k
Irene Koukoulas Australia 18 455 0.7× 411 1.1× 223 0.9× 583 2.8× 63 0.4× 28 1.4k
Oliver Neubauer Austria 18 714 1.1× 501 1.3× 346 1.3× 236 1.1× 164 1.1× 36 1.4k
Rebecca V. Vince United Kingdom 20 213 0.3× 324 0.9× 183 0.7× 157 0.8× 180 1.2× 52 1.1k
Sven Asp Denmark 11 872 1.3× 531 1.4× 372 1.4× 197 1.0× 228 1.5× 12 1.3k
Ulla Ramer Mikkelsen Denmark 21 700 1.1× 571 1.5× 491 1.9× 530 2.6× 176 1.1× 51 1.9k
J. G. Cannon United States 7 333 0.5× 218 0.6× 188 0.7× 210 1.0× 58 0.4× 12 930
Manabu Totsuka Japan 13 720 1.1× 329 0.9× 287 1.1× 83 0.4× 169 1.1× 24 1.1k
Ryo Kakigi Japan 20 252 0.4× 469 1.2× 253 1.0× 409 2.0× 111 0.7× 53 1.0k
Giosuè Annibalini Italy 18 156 0.2× 345 0.9× 168 0.7× 545 2.6× 65 0.4× 41 1.1k
Vilmar Baldissera Brazil 23 235 0.4× 398 1.1× 238 0.9× 93 0.4× 526 3.4× 67 1.4k

Countries citing papers authored by Anders Toft

Since Specialization
Citations

This map shows the geographic impact of Anders Toft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Toft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Toft more than expected).

Fields of papers citing papers by Anders Toft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Toft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Toft. The network helps show where Anders Toft may publish in the future.

Co-authorship network of co-authors of Anders Toft

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Toft. A scholar is included among the top collaborators of Anders Toft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Toft. Anders Toft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nielsen, Jørgen E., et al.. (2025). Immunological Fluid Biomarkers in Frontotemporal Dementia: A Systematic Review. Biomolecules. 15(4). 473–473. 3 indexed citations
2.
Toft, Anders, Simon Sjödin, Anja Hviid Simonsen, et al.. (2023). Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(1). e12402–e12402. 2 indexed citations
3.
Toft, Anders, et al.. (2023). Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review. Neuroscience Applied. 2. 102438–102438.
4.
Toft, Anders, Olli Jääskeläinen, Christian Sandøe Musaeus, et al.. (2020). Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation. Dementia and Geriatric Cognitive Disorders. 49(6). 533–538. 10 indexed citations
5.
Toft, Anders, Steffen Birk, Martin Ballegaard, et al.. (2019). Peripheral neuropathy in hereditary spastic paraplegia caused by REEP1 variants. Journal of Neurology. 266(3). 735–744. 10 indexed citations
6.
Toft, Anders, Thomas Urup, Ib Jarle Christensen, et al.. (2018). Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan. Cancer Investigation. 36(2). 165–174. 4 indexed citations
7.
Piraccini, Bianca Maria, Michela Starace, & Anders Toft. (2018). Rapid cosmetic improvements in nail psoriasis patients treated with K101-03. European Journal of Dermatology. 28(2). 272–274. 2 indexed citations
8.
Piraccini, Bianca Maria, Michela Starace, & Anders Toft. (2017). Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis. Dermatology. 233(2-3). 178–183. 6 indexed citations
9.
Pan, Jiun Yit, et al.. (2017). Rapid Visible Improvements in Onychomycosis: An Open-Label Clinical Investigation of Kerasal Nail<sup>TM</sup>. Journal of Cosmetics Dermatological Sciences and Applications. 7(1). 57–66. 2 indexed citations
10.
Urup, Thomas, Signe Regner Michaelsen, Kristoffer Vitting‐Seerup, et al.. (2017). Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients. BMC Cancer. 17(1). 278–278. 20 indexed citations
11.
Urup, Thomas, Signe Regner Michaelsen, Lars Rønn Olsen, et al.. (2016). Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients. Molecular Oncology. 10(8). 1160–1168. 22 indexed citations
12.
Toft, Anders, Oana Ciofu, A. Briales, et al.. (2013). Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. International Journal of Antimicrobial Agents. 43(2). 140–147. 59 indexed citations
13.
Morgan, Christopher Ll., Marc Evans, Anders Toft, et al.. (2011). Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database Study. Clinical Therapeutics. 33(1). 27–35. 7 indexed citations
14.
Toft, Anders, A Falahati, & Adam Steensberg. (2010). Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model. European Journal of Applied Physiology. 111(7). 1351–1359. 37 indexed citations
15.
Schmidt, Wolfgang E., Stephen Gough, Sten Madsbad, et al.. (2009). Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss. Diabetologia. 52. 5 indexed citations
16.
Gough, S, Kirstine Brown Frandsen, & Anders Toft. (2008). Glycaemic control and cardiovascular risk in insulin-treated patients with type 2 diabetes in Germany and the UK. Diabetologia. 51. 2 indexed citations
17.
Frandsen, Kirstine Brown, et al.. (2006). Failure of insulin monotherapy in patients with type 2 diabetes: A population-based study. Diabetes. 55. 10 indexed citations
18.
Pedersen, Bente Klarlund & Anders Toft. (2000). Effects of exercise on lymphocytes and cytokines. British Journal of Sports Medicine. 34(4). 246–251. 283 indexed citations
19.
Pedersen, Bente Klarlund, et al.. (1999). Exercise and the immune system - influence of nutrition and ageing. Journal of science and medicine in sport. 2(3). 234–252. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Koukoulas Breakdown of academic impact, for papers by Oliver Neubauer Breakdown of academic impact, for papers by Rebecca V. Vince Breakdown of academic impact, for papers by Sven Asp Breakdown of academic impact, for papers by Ulla Ramer Mikkelsen Breakdown of academic impact, for papers by J. G. Cannon Breakdown of academic impact, for papers by Manabu Totsuka Breakdown of academic impact, for papers by Ryo Kakigi Breakdown of academic impact, for papers by Giosuè Annibalini Breakdown of academic impact, for papers by Vilmar Baldissera
Rankless by CCL
2026